VTR (Ventas, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by VTR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Andy Wattula | EVP OM&R-Ventas/Pres&CEO-LHS | A | — | — |
| 2026-07-17 | Joe Vasquez Rodriguez Jr. | Director | A | — | — |
| 2026-07-17 | MARGUERITE M NADER | Director | A | — | — |
| 2026-07-17 | Roxanne M Martino | Director | A | — | — |
| 2026-07-17 | MICHAEL J EMBLER | Director | A | — | — |
| 2026-07-17 | Maurice S Smith | Director | A | — | — |
| 2026-07-17 | Sumit Roy | Director | A | — | — |
| 2026-07-17 | MATTHEW J LUSTIG | Director | A | — | — |
| 2026-07-17 | Melody C Barnes | Director | A | — | — |
| 2026-07-02 | Sumit Roy | Director | A | — | — |
| 2026-07-02 | Roxanne M Martino | Director | A | — | — |
| 2026-07-02 | Maurice S Smith | Director | A | — | — |
| 2026-07-02 | MATTHEW J LUSTIG | Director | A | — | — |
| 2026-06-05 | MICHAEL J EMBLER | Director | Buy | — | — |
| 2026-05-15 | Melody C Barnes | Director | A | — | — |
| 2026-05-15 | THEODORE BIGMAN | Director | A | — | — |
| 2026-05-15 | MICHAEL J EMBLER | Director | A | — | — |
| 2026-05-15 | MATTHEW J LUSTIG | Director | A | — | — |
| 2026-05-15 | Roxanne M Martino | Director | A | — | — |
| 2026-05-15 | MARGUERITE M NADER | Director | A | — | — |
| 2026-05-15 | Sean P. Nolan | Director | A | — | — |
| 2026-05-15 | WALTER C RAKOWICH | Director | MIXED | — | — |
| 2026-05-15 | Joe Vasquez Rodriguez Jr. | Director | A | — | — |
| 2026-05-15 | Sumit Roy | Director | A | — | — |
| 2026-05-15 | Maurice S Smith | Director | A | — | — |
| 2026-05-05 | Peter J. Bulgarelli | EVP OM&R-Ventas/Pres&CEO-LHS | F | — | — |
| 2026-04-17 | Melody C Barnes | Director | A | — | — |
| 2026-04-17 | MICHAEL J EMBLER | Director | A | — | — |
| 2026-04-17 | MATTHEW J LUSTIG | Director | A | — | — |
| 2026-04-17 | Roxanne M Martino | Director | A | — | — |
| 2026-04-17 | MARGUERITE M NADER | Director | A | — | — |
| 2026-04-17 | Joe Vasquez Rodriguez Jr. | Director | A | — | — |
| 2026-04-17 | Sumit Roy | Director | A | — | — |
| 2026-04-17 | Maurice S Smith | Director | A | — | — |
| 2026-04-03 | Roxanne M Martino | Director | A | — | — |
| 2026-04-03 | MATTHEW J LUSTIG | Director | A | — | — |
| 2026-04-03 | Sumit Roy | Director | A | — | — |
| 2026-04-03 | Maurice S Smith | Director | A | — | — |
| 2026-02-13 | Peter J. Bulgarelli | EVP OM&R-Ventas/Pres&CEO-LHS | MIXED | — | — |
| 2026-02-13 | DEBRA A CAFARO | Chairman and CEO | MIXED | — | — |
| 2026-02-13 | James Justin Hutchens | EVP Senior Housing and CIO | MIXED | — | — |
| 2026-02-13 | Robert F Probst | EVP and CFO | MIXED | — | — |
| 2026-02-13 | Carey S. Roberts | EVP and GC | MIXED | — | — |
| 2026-02-10 | DEBRA A CAFARO | Chairman and CEO | MIXED | — | — |
| 2026-02-03 | Peter J. Bulgarelli | EVP OM&R-Ventas/Pres&CEO-LHS | F | — | — |
| 2026-02-03 | DEBRA A CAFARO | Chairman and CEO | MIXED | — | — |
| 2026-02-03 | James Justin Hutchens | EVP Senior Housing and CIO | F | — | — |
| 2026-02-03 | Robert F Probst | EVP and CFO | F | — | — |
| 2026-02-03 | Carey S. Roberts | EVP and GC | F | — | — |
| 2026-01-16 | Melody C Barnes | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 24,915,594 | — |
| — | — | 24,770,619 | — |
| — | 10%+ Owner | 3,700,186 | — |
| — | — | 3,700,186 | — |
| — | Chairman and CEO | 1,271,847 | — |
| — | EVP, Chief Admin. Off., GC | 203,786 | — |
| — | EVP Senior Housing and CIO | 196,542 | — |
| — | President | 190,211 | — |
| — | Director | 189,091 | — |
| — | Strategic Advisor | 183,683 | — |
| — | EVP and CFO | 169,734 | — |
| — | Senior Advisor to the CEO | 142,233 | — |
| — | EVP, Medical Prop. Operations | 131,833 | — |
| — | EVP OM&R-Ventas/Pres&CEO-LHS | 120,554 | — |
| — | Director | 114,427 | — |
| — | Director | 112,110 | — |
| — | Director | 95,663 | — |
| — | EVP and GC | 89,602 | — |
| — | Director | 84,978 | — |
| — | Director | 72,422 | — |
| — | Director | 66,845 | — |
| — | Director | 58,662 | — |
| — | SVP-Medical Prop. Operations | 44,125 | — |
| — | Director | 35,378 | — |
| — | Director | 35,269 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VTR quote page; the site-wide leaderboard is on the insider transactions hub.